Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
iShares US Pharmaceuticals ETF
Eli Lilly's weight-loss drug retatrutide passes obesity trial
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
Pfizer (PFE) earnings in the first quarter of 2026
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. See Press | Corbis News…
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Eli Lilly to acquire Centessa and drugs for sleep disorders
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
Eli Lilly Opposes Trump's MFN Drug Pricing Law, Says CEO Ricks
Dave Ricks, CEO of Eli Lilly, speaks in the Oval Office during an event on weight loss drugs at the…
Eli Lilly GLP-1 Foundayo pill approved for obesity
The US Food and Drug Administration has approved Eli LillyThe GLP-1 pill, the company said, is a major milestone for…
Stocks Soar on Hope for Iran War Resolution; In addition, Lilly suffers a big change in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…